Francesco De Rubertis
InvestorFounderCo-founder and Partner at Medicxi · Board director at Rivus Pharmaceuticals, Inc. · Board director at Minerva Neurosciences
Geneva
About
Francesco De Rubertis pioneered an asset-centric biotech model that builds companies around a few drug assets and scaled it by assembling Centessa Pharmaceuticals as a company-of-companies aggregating asset-centric subsidiaries.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Board director at Rivus Pharmaceuticals, Inc.
Intro paths
In turn, Francesco can intro founders to Rivus Pharmaceuticals, Inc.'s investors below.
Rivus Pharmaceuticals, Inc.'s investors · 3
Board director at Minerva Neurosciences
Intro paths
In turn, Francesco can intro founders to Minerva Neurosciences's investors below.
Minerva Neurosciences's investors · 2
Experience
- Medicxipartnercurrent2016 — present
Deals · 2
Rivus Pharmaceuticals, Inc.Board seat
via Medicxi · filed Jan 2025 · $57M raise
Minerva NeurosciencesBoard seat
via Medicxi · filed Mar 2015 · $31M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Aldena TherapeuticsAlys PharmaceuticalsD3 BioLeviceptOttimo PharmaRivus PharmaceuticalsTOAD Oncology
Investor
CellZomeCentessa PharmaceuticalsGenMabGenSight BiologicsKaerus BiosciencesMicrometMolecular PartnersPanGeneticsParallele BiosciencesProfibrixVaxcyteVersartis
Sources: the firm's website · SEC Form D filings.
Colleagues at Medicxi
Frequently asked questions
- Who is Francesco De Rubertis?
- Francesco De Rubertis pioneered an asset-centric biotech model that builds companies around a few drug assets and scaled it by assembling Centessa Pharmaceuticals as a company-of-companies aggregating asset-centric subsidiaries.
- Where does Francesco De Rubertis work?
- Francesco De Rubertis is Co-founder and Partner at Medicxi and Board director at Rivus Pharmaceuticals, Inc. and Board director at Minerva Neurosciences.
- What does Francesco De Rubertis invest in?
- Francesco De Rubertis invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Francesco De Rubertis sit on?
- Francesco De Rubertis holds tracked board seats at Aldena Therapeutics, Alys Pharmaceuticals, D3 Bio, Levicept, Minerva Neurosciences, Ottimo Pharma, Rivus Pharmaceuticals, Rivus Pharmaceuticals, Inc., TOAD Oncology.
- What companies has Francesco De Rubertis invested in?
- Investments tracked here include CellZome, Centessa Pharmaceuticals, GenMab, GenSight Biologics, Kaerus Biosciences, Micromet, Molecular Partners, PanGenetics, Parallele Biosciences, Profibrix, Vaxcyte, Versartis.